NCT01842672View on ClinicalTrials.gov

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

August 31, 2021

Study Completion Date

September 30, 2022

Conditions
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoblastic LymphomaDiffuse Large B-cell LymphomaBurkitt Lymphoma/Leukemia
Interventions
DRUG

Clofarabine

Dose Escalation of Clofarabine

DRUG

Mitoxantrone

Trial Locations (2)

10595

New York Medical College, Valhalla

28204

Levine Children's Hospital, Charlotte

Sponsors
All Listed Sponsors
lead

New York Medical College

OTHER

NCT01842672 - Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia | Biotech Hunter | Biotech Hunter